Azithromycin (Zithromax)

1505  relevant articles (370 outcomes, 348 trials/studies) found for this Drug

Zithromax; Azadose; Azithromycin Dihydrate; Azithromycin Monohydrate; Azitrocin; Azythromycin; Bayer Brand of Azithromycin Dihydrate; CP-62993; Funk Brand of Azithromycin Dihydrate; Goxal; Lesvi Brand of Azithromycin Dihydrate; Mack Brand of Azithromycin Dihydrate; Pfizer Brand of Azithromycin; Pfizer Brand of Azithromycin Dihydrate; Pharmacia Brand of Azithromycin Dihydrate; Sumamed; Toraseptol; Ultreon; Vinzam; Vita Brand of Azithromycin Dihydrate; Zentavion; Zitromax; Azithromycin Pfizer Brand; CP 62993; CP62993; Dihydrate, Azithromycin; Monohydrate, Azithromycin; 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-

Relationship Network

Drug Context: Research Results

Experts

1.	Skerk, V: 7 articles (02/2006 - 04/2000)
2.	Schönwald, S: 7 articles (08/2004 - 04/2000)
3.	Amsden, Guy W: 6 articles (01/2007 - 03/2003)
4.	Knirsch, Charles: 6 articles (11/2006 - 09/2003)
5.	Dunne, Michael W: 6 articles (12/2005 - 08/2003)
6.	Krhen, I: 6 articles (08/2004 - 12/2000)
7.	Verleden, Geert M: 4 articles (07/2008 - 05/2004)
8.	Prata, Aluízio: 4 articles (05/2008 - 01/2003)
9.	Massae, Patrick A: 4 articles (04/2008 - 09/2003)
10.	Solomon, Anthony W: 4 articles (04/2008 - 09/2003)

Related Diseases

1.	Infection 09/01/2003 - "These results suggest that azithromycin is effective in the prophylaxis and early infection of a highly virulent strain of T" 11/01/1996 - "Although the clinical significance of antibiotic concentrations in these compartments is nuclear, the sustained lung tissue penetration and extensive phagocytic accumulation demonstrated in this study support the proven efficacy of azithromycin administered on a 5-day dosage schedule in the treatment of extracellular or intracellular pulmonary infections." 05/01/2005 - "In contrast, azithromycin was significantly more effective in eradicating persistent infection (MBC(100) = 2.5 to 5.0 microg/ml) than acute infection (MBC(100) = 10 to 50 microg/ml)" 01/01/2004 - "In conclusion, azithromycin was effective for reduction of respiratory symptoms in patients with chronic Cpn infection, but prolonged intermittent treatment with high doses did not eradicate the chronic infection." 05/01/1997 - "We conclude that the long half-life of azithromycin which is beneficial in treating chlamydial infection may result in increased selective pressure for resistance in gonococci" Get all the results and reference details, order at left...
2.	Respiratory Tract Infections (Respiratory Tract Infection) 01/01/1992 - "The efficacy of azithromycin against lower respiratory tract infections has been proven in several clinical studies" 10/01/1994 - "These results suggest that azithromycin may be useful in the treatment of respiratory infections caused by intracellular pathogens, including chlamydia because of its excellent accumulation within host cells." 01/01/2007 - "Efficacy of azithromycin administration in prevention of respiratory tract infection after bronchoscopic biopsy: a randomized, controlled trial." 09/01/1996 - "Azithromycin was given to 55 cases of lower respiratory tract infections in the doses of 500 mg on day 1, followed by 250 mg on days 2-5. It produced bacteriological cure in 70.8% patients and clinical cure or improvement in 69.09% of patients" 09/01/1996 - "Evaluation of safety and efficacy of azithromycin in lower respiratory tract infections (LRTI)" Get all the results and reference details, order at left...
3.	Pneumonia (Pneumonitis) 01/01/2003 - "Azithromycin proved to be effective cure for environmental pneumonia" 09/01/2005 - "We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia" 10/01/1991 - "Side effects were observed in one patient in Group I and in one patient in Group II. The results suggest that a 1.5 g total dose of azithromycin is equally effective when administered as a three- or five-day regimen for the treatment of atypical pneumonia." 03/01/1995 - "This study was designed to evaluate the efficacy of a 3 day course of azithromycin in low to moderately severe community-acquired pneumonia" 06/01/2004 - "Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx]" Get all the results and reference details, order at left...
4.	Otitis Media 08/01/1995 - "Improvement in signs and symptoms of otitis media occurred significantly more rapidly in the children treated with azithromycin" 09/01/1996 - "CONCLUSION: Azithromycin is an effective, safe and well-tolerated treatment for children with acute otitis media." 08/01/2003 - "Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis." 10/01/2005 - "A total of four clinical trials have evaluated the clinical success rate, safety and compliance of single-dose azithromycin (30 mg/kg) in the treatment of children with otitis media" 02/01/2004 - "Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM)" Get all the results and reference details, order at left...
5.	Cystic Fibrosis (Mucoviscidosis) 04/01/2005 - "Azithromycin appears to be safe and effective, and is thus the most promising antiinflammatory therapy available for patients with cystic fibrosis" 11/01/2004 - "The evidence for the clinical benefit of azithromycin in cystic fibrosis has been summarized in a Cochrane review in which a meta-analysis confirmed a significant improvement in forced expiratory volume in 1 second among the 286 pooled participants" 09/28/2002 - "BACKGROUND: The macrolide antibiotic azithromycin has anti-inflammatory properties potentially beneficial in cystic fibrosis" 03/01/2004 - "BACKGROUND: Following reports on the treatment of diffuse panbronchiolitis (DPB), recent studies demonstrate that long term therapy with azithromycin (AZM) is effective in cystic fibrosis (CF) patients" 11/01/2007 - "Azithromycin has antiinflammatory properties and is effective in cystic fibrosis (CF) patients" Get all the results and reference details, order at left...
333 Diseases and 1505 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Clarithromycin (Biaxin)
2.	Erythromycin (Erycette)
3.	Doxycycline (Vibramycin)
4.	Amoxicillin (Wymox)
5.	Ofloxacin (Levofloxacin)
6.	Cyclosporine (Ciclosporin)
7.	Ceftriaxone (Ceftriaxon)
8.	Ciprofloxacin (Cipro)
9.	Macrolides